Skip to main content
Clinical Trials/TCTR20220627002
TCTR20220627002
Unknown
Phase 4

The efficacy and safety of monopolar radiofrequency for treatment of moderate-to-severe recalcitrant acne

Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand0 sites15 target enrollmentJune 27, 2022

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Patient with moderate to severe recalcitrant acne
Sponsor
Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand
Enrollment
15
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 27, 2022
End Date
January 31, 2023
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged from 18 years or older
  • 2\. Were diagnosed with moderate to severe recalcitrant acne by dermatologist
  • 3\. The patient who were not responded by standard treatment, for example, topical treatments and oral antibiotics at least 3 month and have to hold any treatment for 1 month

Exclusion Criteria

  • 1\. Patients who are pregnant, lactating, and postpartum within 1 year
  • 2\. Patients who taking oral isotretinoin within 1 year
  • 3\. Patients with other skin disease, or having infection at the area of face
  • 4\. Immunocompromised patients
  • 5\. Patients with hypertrophic scar or keloid
  • 6\. Patients with history of Cushing syndrome or Ehlers\-Danlos syndromd
  • 7\.Patients with cancers or skin cancers
  • 8\.Patients with mental disorders
  • 9\.Patiens with chemical peels within 1 month
  • 10\. patient with herpes simplex infection

Outcomes

Primary Outcomes

Not specified

Similar Trials